Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$8.12 - $10.37 $893 - $1,140
-110 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$7.48 - $11.38 $822 - $1,251
110 New
110 $1,000
Q2 2021

Aug 11, 2021

SELL
$7.16 - $9.56 $132,610 - $177,060
-18,521 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$8.52 - $19.21 $13,751 - $31,004
-1,614 Reduced 8.02%
18,521 $176,000
Q4 2020

Feb 16, 2021

BUY
$9.3 - $15.19 $53,065 - $86,674
5,706 Added 39.55%
20,135 $187,000
Q3 2020

Nov 12, 2020

BUY
$8.24 - $30.8 $10,341 - $38,654
1,255 Added 9.53%
14,429 $196,000
Q2 2020

Aug 13, 2020

BUY
$7.46 - $23.42 $98,278 - $308,535
13,174 New
13,174 $255,000
Q1 2020

May 14, 2020

SELL
$0.91 - $17.81 $4,869 - $95,301
-5,351 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.88 - $1.12 $4,708 - $5,992
5,350 Added 535000.0%
5,351 $4,000
Q3 2019

Nov 14, 2019

BUY
$0.81 - $1.35 $0 - $1
1 New
1 $0
Q1 2019

May 15, 2019

SELL
$0.96 - $2.24 $920 - $2,148
-959 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.15 - $2.61 $1,102 - $2,502
959 New
959 $0
Q3 2018

Nov 14, 2018

SELL
$2.63 - $4.24 $526 - $848
-200 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$1.62 - $5.28 $324 - $1,056
200 New
200 $0

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $24M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.